The Unusual Presentation of Gastric Adenocarcinoma as a Testicular Mass: A Favorable Response to Docetaxel and Cisplatin Plus Oral Tegafur/Uracil and Leucovorin

Journal of the Chinese Medical Association

Volumn 73, Issue 2, 2010, Pages 88-92

  Yang, Kai Chung ^a,c   Chao, Yee ^a,b,c   Luo, Jiing Chyuan ^a,c   Kuo, Junne Yih ^a,c   Lee, Rheun Chuan ^a,c   Li, Anna Fen Yau ^a,c   Li, Chung Pin ^a,c  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b Central Clinic Hospital   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

gastric cancer; metastasis; testis

Indexed keywords

CISPLATIN; CYTOKERATIN AE1; CYTOKERATIN AE3; DOCETAXEL; FLUOROURACIL; FOLINIC ACID; UFT;

ADULT; ARTICLE; ASCITES; BLOOD EXAMINATION; CANCER RELAPSE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECHOGRAPHY; GASTROSCOPY; HUMAN; HUMAN TISSUE; HYPONATREMIA; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; NORMOCHROMIC NORMOCYTIC ANEMIA; ORCHIECTOMY; PHYSICAL EXAMINATION; SCROTAL PAIN; SCROTAL SWELLING; SKIN METASTASIS; STOMACH ADENOCARCINOMA; STOMACH HEMORRHAGE; STOMACH ULCER; TESTIS CANCER; TREATMENT RESPONSE; TUMOR BIOPSY; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; HUMANS; LEUCOVORIN; MALE; STOMACH NEOPLASMS; TAXOIDS; TEGAFUR; TESTICULAR NEOPLASMS; URACIL;

EID: 77950987686     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/S1726-4901(10)70007-1     Document Type: Article

References (18)

1. Ferlay J., Bray F., Parkin D.M., and Pisani P. Globocan 2000: Cancer Incidence and Mortality Worldwide. IARC Cancer Bases No. 5 (2001), IARC Press, Lyon
2. Lau M., Le A., and El-Serag H.B. Noncardia gastric adenocarcinoma remains an important and deadly cancer in the United States: secular trends in incidence and survival. Am J Gastroenterol 101 (2006) 2485-2492
3. Turan T., Aykan B., Koc S., Boran N., Tulunay G., Karacay O., Erdogan Z., et al. Analysis of metastatic ovarian tumors from extragenital primary sites. Tumori 92 (2006) 491-495
4. Kakushima N., Kamoshida T., Hirai S., Hotta S., Hirayama T., Yamada J., Ueda K., et al. Early gastric cancer with Krukenberg tumor and review of cases of intramucosal gastric cancers with Krukenberg tumor. J Gastroenterol 38 (2003) 1176-1180
5. Grignon D.J., Shum D.T., and Hayman W.P. Metastatic tumours of the testes. Can J Surg 29 (1986) 359-361
6. Kaufman D.S., Saksena M.A., Young R.H., and Tabatabaei S. Case records of the Massachusetts General Hospital. Case 6-2007. A 28-year-old man with a mass in the testis. N Engl J Med 356 (2007) 842-849
7. Dutt N., Bates A.W., and Baithun S.I. Secondary neoplasms of the male genital tract with different patterns of involvement in adults and children. Histopathology 37 (2000) 323-331
8. Haupt H.M., Mann R.B., Trump D.L., and Abeloff M.D. Metastatic carcinoma involving the testis. Clinical and pathologic distinction from primary testicular neoplasms. Cancer 54 (1984) 709-714
9. Qazi H.A., Manikandan R., Foster C.S., and Fordham M.V. Testicular metastasis from gastric carcinoma. Urology 68 (2006) 890 e7-8.
10. Niehans G.A., Manivel J.C., Copland G.T., Scheithauer B.W., and Wick M.R. Immunohistochemistry of germ cell and trophoblastic neoplasms. Cancer 62 (1988) 1113-1123
11. Iczkowski K.A., and Butler S.L. New immunohistochemical markers in testicular tumors. Anal Quant Cytol Histol 28 (2006) 181-187
12. Shah M.A., and Schwartz G.K. Treatment of metastatic esophagus and gastric cancer. Semin Oncol 31 (2004) 574-587
13. Ajani J.A. Evolving chemotherapy for advanced gastric cancer. Oncologist 10 (2005) 49-58
14. Sulkes A., Smyth J., Sessa C., Dirix L.Y., Vermorken J.B., Kaye S., Wanders J., et al. Docetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group. Br J Cancer 70 (1994) 380-383
15. Roth A.D., Maibach R., Martinelli G., Fazio N., Aapro M.S., Pagani O., Morant R., et al. Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO). Ann Oncol 11 (2000) 301-306
16. Ohtsu A., Boku N., Tamura F., Muro K., Shimada Y., Saigenji K., Akazawa S., et al. An early phase II study of a 3-hour infusion of paclitaxel for advanced gastric cancer. Am J Clin Oncol 21 (1998) 416-419
17. Dank M., Zaluski J., Barone C., Valvere V., Yalcin S., Peschel C., Wenczl M., et al. Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction. Ann Oncol 19 (2008) 1450-1457
18. Ajani A.J., Fodor M.B., Tjulandin S.A., Moiseyenko V.M., Chao Y., Filho S.C., Majlis A., et al. Phase II multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma. J Clin Oncol 23 (2005) 5660-5667